Annual total expenses:
$2.91B+$433.24M(+17.49%)Summary
- As of today (September 18, 2025), AMRX annual total expenses is $2.91 billion, with the most recent change of +$433.24 million (+17.49%) on December 31, 2024.
- During the last 3 years, AMRX annual total expenses has risen by +$827.80 million (+39.74%).
- AMRX annual total expenses is now at all-time high.
Performance
AMRX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$702.09M+$18.87M(+2.76%)Summary
- As of today (September 18, 2025), AMRX quarterly total expenses is $702.09 million, with the most recent change of +$18.87 million (+2.76%) on June 30, 2025.
- Over the past year, AMRX quarterly total expenses has increased by +$6.30 million (+0.91%).
- AMRX quarterly total expenses is now -7.81% below its all-time high of $761.60 million, reached on December 31, 2024.
Performance
AMRX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AMRX Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.5% | +0.9% |
| 3 y3 years | +39.7% | +3.2% |
| 5 y5 years | +46.4% | +47.3% |
AMRX Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.7% | -7.8% | +28.1% |
| 5 y | 5-year | at high | +53.1% | -7.8% | +47.3% |
| alltime | all time | at high | >+9999.0% | -7.8% | +2955.4% |
AMRX Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $702.09M(+2.8%) |
| Mar 2025 | - | $683.23M(-10.3%) |
| Dec 2024 | $2.91B(+17.5%) | $761.60M(+8.4%) |
| Sep 2024 | - | $702.62M(+1.0%) |
| Jun 2024 | - | $695.79M(-7.3%) |
| Mar 2024 | - | $750.83M(+4.9%) |
| Dec 2023 | $2.48B(+5.8%) | $715.63M(+17.2%) |
| Sep 2023 | - | $610.36M(+4.0%) |
| Jun 2023 | - | $587.13M(+4.0%) |
| Mar 2023 | - | $564.48M(-8.1%) |
| Dec 2022 | $2.34B(+12.4%) | $614.09M(+12.0%) |
| Sep 2022 | - | $548.25M(-19.4%) |
| Jun 2022 | - | $680.16M(+36.1%) |
| Mar 2022 | - | $499.79M(-8.0%) |
| Dec 2021 | $2.08B(+9.5%) | $543.27M(+2.0%) |
| Sep 2021 | - | $532.83M(+2.4%) |
| Jun 2021 | - | $520.54M(+7.0%) |
| Mar 2021 | - | $486.40M(-5.2%) |
| Dec 2020 | $1.90B(-4.4%) | $513.07M(-2.9%) |
| Sep 2020 | - | $528.27M(+10.8%) |
| Jun 2020 | - | $476.66M(+24.3%) |
| Mar 2020 | - | $383.47M(-10.7%) |
| Dec 2019 | $1.99B(+18.1%) | $429.46M(-33.2%) |
| Sep 2019 | - | $643.29M(+52.6%) |
| Jun 2019 | - | $421.54M(-14.7%) |
| Mar 2019 | - | $494.00M(-2.4%) |
| Dec 2018 | $1.68B(+62.9%) | $506.30M(+7.8%) |
| Sep 2018 | - | $469.54M(+8.5%) |
| Jun 2018 | - | $432.89M(+57.3%) |
| Mar 2018 | - | $275.19M(-6.2%) |
| Dec 2017 | $1.03B(-20.3%) | $293.37M(+15.2%) |
| Sep 2017 | - | $254.73M(-2.0%) |
| Jun 2017 | - | $259.87M(>+9900.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $1.30B(+57.8%) | - |
| Dec 2016 | - | $478.01M(+17.4%) |
| Sep 2016 | - | $407.25M(+132.3%) |
| Jun 2016 | - | $175.29M(-25.7%) |
| Mar 2016 | - | $235.92M(-12.8%) |
| Dec 2015 | $821.47M(+52.5%) | $270.67M(+46.0%) |
| Sep 2015 | - | $185.34M(-14.2%) |
| Jun 2015 | - | $216.03M(+44.6%) |
| Mar 2015 | - | $149.43M(+14.0%) |
| Dec 2014 | $538.70M(+31.3%) | $131.09M(-7.9%) |
| Sep 2014 | - | $142.26M(-7.0%) |
| Jun 2014 | - | $153.05M(+36.3%) |
| Mar 2014 | - | $112.29M(+1.7%) |
| Dec 2013 | $410.24M(-22.0%) | $110.36M(-16.9%) |
| Sep 2013 | - | $132.82M(+7.1%) |
| Jun 2013 | - | $124.01M(+188.1%) |
| Mar 2013 | - | $43.05M(-68.4%) |
| Dec 2012 | $525.82M | $136.28M(+8.5%) |
| Sep 2012 | - | $125.55M(-15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $147.79M(+27.2%) |
| Mar 2012 | - | $116.20M(-15.0%) |
| Dec 2011 | $447.42M(-28.9%) | $136.70M(+33.2%) |
| Sep 2011 | - | $102.63M(-9.4%) |
| Jun 2011 | - | $113.31M(+19.5%) |
| Mar 2011 | - | $94.79M(+9.4%) |
| Dec 2010 | $629.09M(+104.0%) | $86.68M(-62.1%) |
| Sep 2010 | - | $228.83M(+88.0%) |
| Jun 2010 | - | $121.73M(-36.5%) |
| Mar 2010 | - | $191.85M(+39.0%) |
| Dec 2009 | $308.35M(+61.1%) | $137.99M(+136.8%) |
| Sep 2009 | - | $58.26M(+5.2%) |
| Jun 2009 | - | $55.40M(-2.3%) |
| Mar 2009 | - | $56.69M(+59.1%) |
| Dec 2008 | $191.37M(+29.5%) | $35.64M(-22.0%) |
| Sep 2008 | - | $45.69M(-25.2%) |
| Jun 2008 | - | $61.08M(+24.7%) |
| Mar 2008 | - | $48.97M(-19.7%) |
| Dec 2007 | $147.83M(+0.4%) | $60.97M(-12.9%) |
| Sep 2007 | - | $70.02M(-384.8%) |
| Jun 2007 | - | -$24.59M(-159.3%) |
| Mar 2007 | - | $41.43M(+2.9%) |
| Dec 2006 | $147.29M(+24.6%) | $40.25M(+15.6%) |
| Sep 2006 | - | $34.81M(-11.8%) |
| Jun 2006 | - | $39.47M(+20.4%) |
| Mar 2006 | - | $32.77M(+9.4%) |
| Dec 2005 | $118.18M(+61.8%) | - |
| Sep 2004 | - | $29.97M(-0.9%) |
| Jun 2004 | - | $30.24M(+3.1%) |
| Mar 2004 | - | $29.33M(+33.7%) |
| Dec 2003 | $73.03M(+63.9%) | $21.93M(+9.1%) |
| Sep 2003 | - | $20.11M(+23.0%) |
| Jun 2003 | - | $16.35M(+11.7%) |
| Mar 2003 | - | $14.64M(+23.3%) |
| Dec 2002 | $44.55M(+40.5%) | $11.87M(-6.9%) |
| Sep 2002 | - | $12.75M(+15.0%) |
| Jun 2002 | - | $11.08M(+25.2%) |
| Mar 2002 | - | $8.85M(-0.3%) |
| Dec 2001 | $31.70M(-9.0%) | $8.88M(+5.4%) |
| Sep 2001 | - | $8.43M(+15.7%) |
| Jun 2001 | - | $7.29M(+2.5%) |
| Mar 2001 | - | $7.11M(+0.1%) |
| Dec 2000 | $34.84M(+242.0%) | $7.10M(-42.7%) |
| Sep 2000 | - | $12.39M(+53.9%) |
| Jun 2000 | - | $8.05M(+16.6%) |
| Mar 2000 | - | $6.91M(>+9900.0%) |
| Dec 1999 | $10.19M(+13.0%) | $0.00(-100.0%) |
| Sep 1999 | - | $3.04M(-2.6%) |
| Jun 1999 | - | $3.12M(+17.6%) |
| Mar 1999 | - | $2.65M(+1.7%) |
| Dec 1998 | $9.02M | $2.60M(+21.4%) |
| Sep 1998 | - | $2.15M(-9.8%) |
| Jun 1998 | - | $2.38M(+26.0%) |
| Mar 1998 | - | $1.89M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual total expenses?
- What is the all time high annual total expenses for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual total expenses year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual total expenses?
The current annual total expenses of AMRX is $2.91B
What is the all time high annual total expenses for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual total expenses is $2.91B
What is Amneal Pharmaceuticals, Inc. annual total expenses year-on-year change?
Over the past year, AMRX annual total expenses has changed by +$433.24M (+17.49%)
What is Amneal Pharmaceuticals, Inc. quarterly total expenses?
The current quarterly total expenses of AMRX is $702.09M
What is the all time high quarterly total expenses for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly total expenses is $761.60M
What is Amneal Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
Over the past year, AMRX quarterly total expenses has changed by +$6.30M (+0.91%)